Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision bumped from v3.6.2 to v3.6.3, indicating a small update to the site’s revision metadata and backend; it does not alter the displayed study details or page structure.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page revision was updated to v3.6.2, replacing v3.6.0, indicating a newer version of the study page content and metadata. This appears to be a minor technical update rather than a substantive change to study information.SummaryDifference0.0%

- Check33 days agoChange DetectedRecruitment status updated to not actively recruiting and enrollment updated to 70 participants. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the study timeline was updated to show primary completion on 2027-12-31 and study completion on 2030-12-31.SummaryDifference1%

- Check41 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, reflecting a minor update to the page metadata. The change represents an internal update to the ClinicalTrials.gov entry rather than a modification to the study content or results.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page's template or backend. No study content or user-facing information was changed.SummaryDifference0.0%

- Check69 days agoChange DetectedNo additions or deletions are listed. The supplied change data contains no textual changes for this page.SummaryDifference0.0%

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.